Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. - Wikidata - awgldk - TriplyDB

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

http://www.wikidata.org/entity/Q38395321

about

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer Cell-free circulating tumor DNA in cancer Upcoming translational challenges for uveal melanoma Recent developments in prognostic and predictive testing in uveal melanoma Liquid biopsies: genotyping circulating tumor DNA Clinical applications of liquid biopsies in gastrointestinal oncology Uveal Melanoma: Current Trends in Diagnosis and Management Pharmacologic biomarkers in the development of stratified cancer medicine.The feasibility of using mutation detection in ctDNA to assess tumor dynamics.Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method.Detection of circulating melanoma cells in choroidal melanocytic lesions.Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA Circulating Cell-Free Tumour DNA in the Management of Cancer.Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.Circulating tumor DNA: a resuscitative gold mine?Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.The biology of uveal melanoma Next-generation sequencing technologies: breaking the sound barrier of human genetics.Uveal melanoma: non-invasive predictive testing.Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.Metastatic pathways in patients with cutaneous melanoma.Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA.Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.Cell-Free DNA in Oncology: Gearing up for Clinic.Liquid biomarkers in melanoma: detection and discovery.Correlation between circulating tumor cells and D-D and platelet in patients with pulmonary malignancies.Improving the CellSearch® system.MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.Neueste technologische Entwicklungen für die Analyse von zirkulierender Tumor-DNA

P2860

Q26746010-B03D527A-2E34-409B-A02A-347DA24EBACD Q26750899-C6B1237E-B8A1-4D25-9DA7-BB45561CB46C Q26778535-9EDE3702-8901-45D0-8C00-2B1261D31289 Q26824096-A57B0761-82A5-4F4A-9AED-89A74BB062DC Q27010159-86EF1608-C40C-4BB3-9233-99A78528E0C1 Q28073730-C8973F84-3F3B-48F7-AF92-5D34F92073C5 Q28073924-6C9D0500-B824-40B8-ACFD-51C4C0819893 Q33626476-EC0A6B65-EA82-420E-AB89-62ADC72B8B15 Q33697983-880FEF9E-DBBA-4AA3-B724-06CEC53A4765 Q35090294-D583B728-33A1-42F9-B15D-BB4236B18316 Q35780352-3679E8D6-8EE2-4A58-A889-427C9D10DAA5 Q35810461-6C021D58-4BBB-44C8-A268-2CFA5CC90EF1 Q35814162-0305A041-8D64-49CB-AE98-F662618F02D5 Q36073981-178DA6D2-265C-4558-960C-DDFAB5A8E68B Q36204919-E1E2CEC6-8E56-48B8-A6A6-9B98F90647FB Q36443927-6C81144B-DDAF-4583-8D6E-153A735E7573 Q36452245-DD5D1A93-EC49-4DDA-9866-A994AB73D9DA Q36540937-09F1E4B6-C50B-4800-A62C-0DC8ABFD12D5 Q37110941-CD45EE8D-A28D-4433-A4BD-7058CEF872BA Q37687088-30B78CA5-D03E-4AB0-9F03-CF2A837D99C3 Q37742632-2266EAAF-79AA-4DCB-AF04-2CF59E86EBBB Q38242485-AE1DEE87-5832-4EBB-80FF-1E30C333E847 Q38307829-A1C6FC3F-6FC0-423D-B0C0-B1BECC7150BA Q38389809-6DB53A4B-9120-4722-B0A0-21AF19AF24F9 Q38513661-4D3733A3-9D8F-49A0-A913-DE1EC55CC71C Q39024316-4B19C4CE-0920-48D0-AA2C-27F6CFBF31BC Q39292740-115EE3F1-3083-4241-BAEB-4325357DD4DF Q40149888-1EE52E80-49FD-4C05-9B2B-40FDB0DAA74C Q40441542-7002A71E-5F77-4DF2-8FA2-6C924772D43B Q41932233-557B8D47-D629-47C3-8DB0-799E0B41D067 Q42654048-9E1E3266-A2F5-4EBD-BB7E-9B6086A701D4 Q42687570-68DDAF34-413C-4A20-A7EE-A59620D51E54 Q47120556-ED8FDB30-C15D-45ED-B5F2-07E096C1227C Q47142145-EBE4E734-E7B4-4BB8-AA3A-119A589341A5 Q47726847-7A623A29-AE6B-4F0F-9877-7075A9B6A8D3 Q50053615-4884DC39-F9A5-4DE0-A6A4-CE0B809A7668 Q51115531-C2E28414-FFEF-4871-A8AB-84CCDB77CDDB Q55491411-1E761102-24D0-469A-B0C7-81D57A892A07 Q57636579-BAF58789-7A81-436F-9C3B-17B6DCB9D7BF

P2860

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

http://www.wikidata.org/entity/Q38395321

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Detection rate and prognostic ...... in metastatic uveal melanoma.

@en

type

label

Detection rate and prognostic ...... in metastatic uveal melanoma.

@en

prefLabel

Detection rate and prognostic ...... in metastatic uveal melanoma.

@en

P1433

Q38395321-07D4B463-C74C-4947-9C3D-EFC3E9E80347

P1476

Q38395321-C0275DE1-C800-4784-AD9E-8D66B22480D9

P2093

Q38395321-070A6712-B491-4EF2-84DE-ED7A89B2A2D1

Q38395321-262EBDCD-A2EC-4335-ABD2-D7B50236E41D

Q38395321-5A6B8A9F-6679-4664-A37C-B171BB33CD0C

Q38395321-623890CB-B46B-4CF6-8FAE-5D2081A7F2FF

Q38395321-78694278-1EF5-48F1-8758-D2FEC15B75D7

Q38395321-9041171F-AE7A-4711-9F0B-D39031276704

Q38395321-984A7102-1416-43AE-9728-A4F53E41B680

Q38395321-BC89596F-A8CE-4FE8-B2B3-189A2A9707EE

Q38395321-D25A5AC5-1BB8-40BC-A4BD-1FC18AD70F51

Q38395321-F954EFA4-0B3E-4612-87EE-24D3877FE664

P2860

Q38395321-070F934E-95BA-49BB-A9F0-1CBC1BDDE3D4

Q38395321-09FE07E4-8940-4C91-8D09-BE6B751DD3C4

Q38395321-22180DD0-05A7-4E17-A238-B39CA9E2C690

Q38395321-3A3E238C-CE78-45CA-9D0F-B9EBB62EC232

Q38395321-3A53E048-81E6-4674-AFEC-CA6761881915

Q38395321-41586FC5-5CFE-4572-AB72-15AEED914E95

Q38395321-4C6813EB-D9D6-4169-BEDC-C716D10C3B38

Q38395321-4F94E32D-6D16-456B-8DCA-8192BD1A0F7B

Q38395321-54718E14-5168-4AC9-8AE3-15667ACF150D

Q38395321-6B84440B-25DE-48AB-9304-90B43185B01C

P304

Q38395321-CA5F4AC4-36D7-49D9-9FFD-BD25A685A274

P31

Q38395321-09E34341-B980-4184-A81C-6F9EC97D56AD

P356

Q38395321-5C00CDEE-A547-438B-B7E8-2E3AA4AF53F2

P433

Q38395321-F69DD6A6-7937-4F2F-A927-7E5E803EBFE4

P478

Q38395321-B43C6779-79F7-421D-BBEC-D0713BA3B67F

P50

Q38395321-0CB6820D-5240-4540-8F2F-2CD1027B50A3

Q38395321-164864F2-C4FF-44BE-BA63-4EEC7DD62B41

Q38395321-43F881A1-34C0-41C3-8EB4-C9114C106645

Q38395321-D5AE6A18-C081-4AE6-9BEE-23421101D61C

P577

Q38395321-76DF0AD7-15D0-482C-8C78-7EB9C2FDDA5E

P5875

Q38395321-A676297E-9173-4D36-B0E7-56328EF2D4B1

P698

Q38395321-FDA7A554-2ECB-4204-8B3D-301D2D72FA22

P356

P1433

International Journal of Cancer

P1476

Detection rate and prognostic ...... in metastatic uveal melanoma.

@en

P2093

Aurore Rampanou

http://www.w3.org/2001/XMLSchema#string

François-Clément Bidard

http://www.w3.org/2001/XMLSchema#string

Isabelle Vaucher

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Pierga

http://www.w3.org/2001/XMLSchema#string

Jordan Madic

http://www.w3.org/2001/XMLSchema#string

Laurence Desjardins

http://www.w3.org/2001/XMLSchema#string

Maud Milder

http://www.w3.org/2001/XMLSchema#string

Nathalie Cassoux

http://www.w3.org/2001/XMLSchema#string

Pascale Mariani

http://www.w3.org/2001/XMLSchema#string

Ronald Lebofsky

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in GNA11 in uveal melanoma

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

Circulating mutant DNA to assess tumor dynamics

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.

Cell-free nucleic acids as biomarkers in cancer patients.

Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.

Incidence of uveal melanoma in the United States: 1973-1997.

P304

1207-1213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.28436

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Piperno-Neumann

Marc-Henri Stern

P577

2013-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255735965

http://www.w3.org/2001/XMLSchema#string

P698

23934701

http://www.w3.org/2001/XMLSchema#string